Evaluating the Effect on Mortality of a No-Tranexamic acid (TXA) Policy for Cardiovascular Surgery
Click the title to purchase the article.
Objectives: "The authors stopped using tranexamic acid (TXA) in April 2013. The present study aimed to examine the impact of a “no-TXA-use” policy by comparing the adverse effects of TXA and clinical outcomes before and after the policy change in patients undergoing cardiovascular surgery."1
1. Evaluating the Effect on Mortality of a No-Tranexamic acid (TXA) Policy for Cardiovascular Surgery
Maeda T, Ishihara T, Miyata S, Yamashita K, Sasaki H et al.
J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1627-1634
Editorial